BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 18307500)

  • 1. Pharmacokinetics of total thyroxine in dogs after administration of an oral solution of levothyroxine sodium.
    Le Traon G; Burgaud S; Horspool LJ
    J Vet Pharmacol Ther; 2008 Apr; 31(2):95-101. PubMed ID: 18307500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of cimetidine in dogs after oral administration of cimetidine tablets.
    Le Traon G; Burgaud S; Horspool LJ
    J Vet Pharmacol Ther; 2009 Jun; 32(3):213-8. PubMed ID: 19646084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.
    Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD
    Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of two L-thyroxine formulations after oral administration to healthy dogs.
    Simpson C; Devi JL; Whittem T
    Aust Vet J; 2013 Mar; 91(3):83-8. PubMed ID: 23438458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in dogs.
    Park BK; Lim JH; Kim MS; Hwang YH; Yun HI
    Res Vet Sci; 2008 Feb; 84(1):85-9. PubMed ID: 17570454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparative plasma pharmacokinetics of intravenous cefpodoxime sodium and oral cefpodoxime proxetil in beagle dogs.
    Brown SA; Boucher JF; Hubbard VL; Prough MJ; Flook TF
    J Vet Pharmacol Ther; 2007 Aug; 30(4):320-6. PubMed ID: 17610405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clindamycin bioavailability and pharmacokinetics following oral administration of clindamycin hydrochloride capsules in dogs.
    Batzias GC; Delis GA; Athanasiou LV
    Vet J; 2005 Nov; 170(3):339-45. PubMed ID: 16266847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of L-thyroxine after its oral administration in dogs.
    Nachreiner RF; Refsal KR; Ravis WR; Hauptman J; Rosser EJ; Pedersoli WM
    Am J Vet Res; 1993 Dec; 54(12):2091-8. PubMed ID: 8116944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition and safety of zonisamide after intravenous and oral single dose and oral multiple dosing in normal hound dogs.
    Boothe DM; Perkins J
    J Vet Pharmacol Ther; 2008 Dec; 31(6):544-53. PubMed ID: 19000278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid replacement in thyroparathyroidectomized dogs.
    Hulter HN; Gustafson LE; Bonner EL; Toto RD; Mackie S
    Miner Electrolyte Metab; 1984; 10(4):228-32. PubMed ID: 6749069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of huperzine A in dogs following single intravenous and oral administrations.
    Chu D; Liu W; Li Y; Li P; Gu J; Liu K
    Planta Med; 2006 May; 72(6):552-5. PubMed ID: 16773540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of inhibiting cytochrome P450 3A, p-glycoprotein, and gastric acid secretion on the oral bioavailability of methadone in dogs.
    Kukanich B; Lascelles BD; Aman AM; Mealey KL; Papich MG
    J Vet Pharmacol Ther; 2005 Oct; 28(5):461-6. PubMed ID: 16207309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of a novel liquid formulation of L-thyroxine for once daily treatment of dogs with hypothyroidism.
    Le Traon G; Brennan SF; Burgaud S; Daminet S; Gommeren K; Horspool LJ; Rosenberg D; Mooney CT
    J Vet Intern Med; 2009; 23(1):43-9. PubMed ID: 19175719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of type of diet on pharmacokinetics of levothyroxine sodium oral solution.
    Iemura R; Toyota M; Micallef MJ
    Res Vet Sci; 2013 Jun; 94(3):695-7. PubMed ID: 23357653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of controlled-release carbimazole tablets support once daily dosing in cats.
    Frénais R; Burgaud S; Horspool LJ
    J Vet Pharmacol Ther; 2008 Jun; 31(3):213-9. PubMed ID: 18471142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of total thyroxine after repeated oral administration of levothyroxine solution and its clinical efficacy in hypothyroid dogs.
    van Dijl IC; Le Traon G; van de Meulengraaf BD; Burgaud S; Horspool LJ; Kooistra HS
    J Vet Intern Med; 2014; 28(4):1229-34. PubMed ID: 24773132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M; Lees P; Seewald W; King JN
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the pharmacokinetic properties of bisoprolol and carvedilol in healthy dogs.
    Beddies G; Fox PR; Papich MD; Kanikanti VR; Krebber R; Keene BW
    Am J Vet Res; 2008 Dec; 69(12):1659-63. PubMed ID: 19046015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciprofloxacin pharmacokinetics and oral absorption of generic ciprofloxacin tablets in dogs.
    Papich MG
    Am J Vet Res; 2012 Jul; 73(7):1085-91. PubMed ID: 22738062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Posologic equivalents of oral L-thyroxine in thyroid insufficiency (120 cases)].
    Ann Med Interne (Paris); 1983; 134(7):636-42. PubMed ID: 6666901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.